Cardiomyocyte-Specific Inhibition of p53 Signaling as a Therapeutic Strategy for Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.

Lalaguna L, López-Olañeta M, Torroja C, Relaño-Rupérez C, Fernández-Sellers C, Sánchez-Cabo F, Ochoa JP, Zorio E, García-Pavía P, Lara-Pezzi E

Open source

DOI: 10.1161/circresaha.126.328827
Published: 2026 Sep 11
Container: Circulation research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/circresaha.126.328827,
  title = {Cardiomyocyte-Specific Inhibition of p53 Signaling as a Therapeutic Strategy for Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.},
  author = {Lalaguna L and López-Olañeta M and Torroja C and Relaño-Rupérez C and Fernández-Sellers C and Sánchez-Cabo F and Ochoa JP and Zorio E and García-Pavía P and Lara-Pezzi E},
  year = {2026},
  journal = {Circulation research},
  doi = {10.1161/circresaha.126.328827},
  url = {https://doi.org/10.1161/circresaha.126.328827}
}

RIS

TY  - JOUR
TI  - Cardiomyocyte-Specific Inhibition of p53 Signaling as a Therapeutic Strategy for Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.
AU  - Lalaguna L
AU  - López-Olañeta M
AU  - Torroja C
AU  - Relaño-Rupérez C
AU  - Fernández-Sellers C
AU  - Sánchez-Cabo F
AU  - Ochoa JP
AU  - Zorio E
AU  - García-Pavía P
AU  - Lara-Pezzi E
PY  - 2026
JO  - Circulation research
DO  - 10.1161/circresaha.126.328827
UR  - https://doi.org/10.1161/circresaha.126.328827
ER  -

APA

L, L., M, L., C, T., C, R., C, F., F, S., JP, O., E, Z., P, G., & E, L. (2026). Cardiomyocyte-Specific Inhibition of p53 Signaling as a Therapeutic Strategy for Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.. Circulation research. https://doi.org/10.1161/circresaha.126.328827

Source records

pubmed · retrieved 2026-09-26T19:40:38.099Z